GTBIF (Green Thumb Industries) Future 3-5Y EPS without NRI Growth Rate : 35.36 (As of Jan. 18, 2025)

View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate is 35.36.

Competitive Comparison of Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate falls into.

Green Thumb Industries (OTCPK:GTBIF) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Green Thumb Industries Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Green Thumb Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

R9U2:Germany R9U2:Germany GTII:Canada

Address

325 West Huron Street, Suite 700, Chicago, IL, USA, 60654

Website

https://www.gtigrows.com

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RYTHM.

Executives

Richard Reisin	director	325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan	director	660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes	director	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz	officer: GENERAL COUNSEL AND SECRETARY	325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman	director	325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler	director	200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter	director	6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu	director	325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner	officer: Chief Accounting Officer	325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk	officer: General Counsel	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler	director, 10 percent owner, officer: Chairman & CEO	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian	officer: President	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley	other: Chief Strategy Officer	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore	director	325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654